|
Mean (SD) |
Median |
Min-max score |
Cronbach’s α |
IPQ-R: |
|
|
|
|
Illness identity (n=237) |
6.73
(3.37) |
6.00 |
1-14 |
N/A |
Timeline (n=314) |
21.36
(4.16) |
22.00 |
10-30 |
0.80 |
Timeline cyclical (n=315) |
12.78
(3.18) |
13.00 |
4-20 |
0.70 |
Consequences (n=314) |
15.77
(4.42) |
15.00 |
6-29 |
0.78 |
Personal control (n=314) |
18.88
(2.95) |
19.00 |
10-26 |
0.74 |
Treatment control (n=314) |
14.64
(1.92) |
15.00 |
9-20 |
0.77 |
Illness coherence (n=314) |
17.85
(4.50) |
19.00 |
5-25 |
0.91 |
Emotional representations (n=314) |
11.57
(3.94) |
11.00 |
5-25 |
0.85 |
|
|
|
|
|
BMQ-Specific(n reflects number reporting use of medication) |
Necessity |
|
|
|
|
Oral antihistamines
(n=254) |
14.85
(4.23) |
15.00 |
5-25 |
0.83 |
Nasal spray
(n=189) |
14.30
(4.25) |
14.00 |
5-25 |
0.86 |
Eye drops
(n=143) |
13.17
(3.83) |
12.00 |
5-22 |
0.82 |
|
|
|
|
|
Concerns |
|
|
|
|
Oral antihistamines
(n=258) |
12.00
(3.44) |
12.00 |
5-21 |
0.71 |
Nasal spray
(n=191) |
12.25
(3.39) |
12.00 |
5-21 |
0.76 |
Eye drops
(n=143) |
10.76
(3.36) |
10.00 |
5-20 |
0.84 |
|
|
|
|
|
